CD47 and neoplasm: The biodistribution of CAR-Ms in CT26 tumor-bearing mice corroborated these results (Fig. S5F), with the accumulation of CAR-Ms in the tumor of mice intratumorally injected with oAd CD47 increased (Fig. S5G).